Personalise our website.
Select your location
United Kingdom
Select your language
English
Select your currency
GBP (£)
Not your country? Click to change.
Basket Contents
Problems ordering? Please call us on +44 01904-789559
Secure Shopping
Free UK Delivery
Worldwide Delivery

Resistant Enterococcal Infections

Enterococci are part of the normal intestinal flora of humans and animals. We have a symbiotic and positive relationship with enterococci, but they are increasingly seen as dangerous pathogens to humans and ones that pose severe risks since they have a natural resistance to antibiotics.

Enterococcus faecalis and Enterococcus faecium are the most frequently identified species accounting for more than 90% of clinical practice isolates out of a possible 17 enterococci that we know of. Enterococcus faecium accounts for most vancomycin-resistant enterococci (VRE) infections.

Enterococci have both a natural and acquired resistance to antibiotics, which is why they are of such grave concern to doctors and nursing staff and why they have their place on the disturbing list of hospital-acquired pathogens.

Recent research offers an exciting way forward suggesting, as it does that probiotics are useful effective allies in the battle with Enterococci, but above all Probiotic Blend s which contain Lactobacillus Rhamnosus GG.

What is Lactobacillus Rhamnosus?

L. Rhamnosusis a probiotic bacterium. In 1983 Goldin and Gorbach found L.Rhamnosusin the human gut and proved that it was resilient enough to survive the high levels of acidity in the stomach and gastrointestinal tract. The strain is named L. Rhamnosus GG after the surnames of its discoverers.

Lactobacillus GG has been the subject of over 400 published studies that document its remarkable properties and justify its reputation as a major immunobiotic and factor in promoting good health.The protective effect of Lr1505 is associated with increased levels of mucosal IgA antibodies. Lactobacillus GG was first isolated from a healthy human in 1985.

And since then Lactobacillus GG research has shown it to be a trusted, efficient, effective immune-boosting probiotic, to the extent that social health programs, such as in Argentina, are proving its benefits by reducing illness in children.

Probiotics are taken for a number of health benefits.You may well be familiar with the probiotic products that are advertised on television as being able to help with digestion and to maintain regular bowel habits. However, many of these products can also contain harmful sugars (e.g. aspartame and sucralose or High Fructose Corn Syrup, or), binders and fillers and they may even provide too few active bacteria to be of any real benefit.

So, can we get all we need from food?

The answer is yes, to some extent, if we eat enough of certain types of food such as fermented foods or certain cheeses: Parmigiano cheese, for example, can have up to 10 million CFU of viable lactic acid bacteria per gram.

Drastically limit or completely cut out sugary food and drinks is an excellent way to maintain a healthy balance of flora in the mouth, gut and the whole body. Consider also adding probiotic-laden foods and beverages and fermented foods daily because the evidence for this overall improving health seems proven in one research paper after another.

But the problem, as we know is the word “daily” and most people, leading busy lives find that an easier way to ensure a healthy balance systemically is to supplement with a quality probiotic.

Why choose a probiotic supplement containing L. Rhamnosus?

  • L. Rhamnosus has been shown to successfully treat gastrointestinal carriage of Antibiotic Resistant Enterococcus in renal patients (Manleyet al, 2007)

  • Often, harmful bacteria can take a hold in the gut as a result of infections or antibiotic use. Harmful bacteria can overcrowd beneficial bacteria, off-balancing the gut. Supplementation with L.Rhamnosus encourages the growth of beneficial bacteria, allowing them to re-colonise the gut and inhibit the overgrowth of harmful bacteria and yeast colonies such as candida.

  • L. Rhamnosusis one of few probiotics that can survive the harsh environment of the gut, and that is ‘bile stable'-meaning that it can fight illnesses of the gut (Conway, et al, 1987)

  • A daily dose of L.Rhamnosus Gr-1 has shown some effectiveness for treating chronic urinary tract infections in postmenopausal women by preventing pathogens from adhering to the urogenital tract.

  • L.Rhamnosus has also been shown to reduce the symptoms of lactose intolerance when the probiotic is combined with milk.

  • L.Rhamnosus has also been shown to reduce the duration of episodes of diarrhoea caused by antibiotic use (to treatH. Pylori) and rotavirus in children (Pelto et al, 1998;Guandaliniet al , 2000;Armuzziet al, 2001)

  • L.Rhamnosus has been shown to be effective in reducing the symptoms of Irritable Bowel Syndrome (Rose, 2011)

  • L. Rhamnosusis widely recognised as being effective in maintaining digestive health and treating a number of antibiotic-resistant strains. It can regularly be taken as a probiotic supplement and is capable of surviving the harsh conditions of the gut where it can get to work. It is just one of the many beneficial probiotics found in Sweet Cures Probiotic Blend™ .

For the vast majority of people, daily probiotics produce wonderful health benefits. It is advised not take L.Rhamnosus supplementation if you suffer from a short-bowel syndrome, a weakened immune system or if pregnant or breastfeeding.

  • Probiotics are generally regarded as safe for human consumption.

  • Use cautiously if compromised immune system, such as those with HIV/AIDS, or in infants born prematurely.

  • Use cautiously if sensitive or intolerant to dairy products containing probiotics. Lactose-sensitive people can develop abdominal discomfort from dairy products.

  • Use extremely cautiously if suffering from pancreatitis. Seek medical advice always.

  • Avoid if there is known allergy or sensitivity to probiotics.

Related Links

Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial.
Manley, K, et al., Med J Aust., 2007;186(9):454.

Lactobacillus Rhamnosus GG clears vancomyc in resistant enterococci
www.thefreelibrary.com

Probiotic treatment vancomycin resistant enterococci randomised controlled trial
www.mja.com.au

Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG.
Gorbach SL, et al., Lancet,1987;2(8574):1519.

Related Products

Probiotic Blend

Trusted Payment Providers

PayPal Logo
WorldPay Payments Processing